Asthma Inhalers Warning

Featured Article

The U.S. Food and Drug Administration (FDA) is again concerned about the safety of four popular asthma inhalers. Two federal safety officials wrote an assessment that claimed patients were risking death if they continued to take Advair, Symbicort, Serevent and Foradil. A third official recommended that Advair and Symbicort should be used only by adults, and by patients who suffer from chronic obstructive pulmonary disease. As a result of the disgareement, an FDA advisory panel is scheduled to...

Read more

More information on "Asthma Inhalers Warning"

From Our Experts

See more SharePosts »

From Our Sources

More on Asthma »